Lowenthal Richard E

ARS Pharmaceuticals, Inc. · PRESIDENT AND CEO

Lowenthal Richard E is listed in public filings as director, 10 percent owner, officer: PRESIDENT AND CEO. This Lowenthal Richard E insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ARS Pharmaceuticals, Inc. (SPRY). Investors use Lowenthal Richard E's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ARS Pharmaceuticals, Inc.SPRY$10M875k sharesGrant / ExerciseJan 2, 2026$10.1M875k shares$11.49--
ARS Pharmaceuticals, Inc.SPRY$2.8M240k sharesGrant / ExerciseJan 2, 2026$2.8M240k shares$11.49--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ARS Pharmaceuticals, Inc.SPRY$17M1.2M sharesSellAug 21, 2025$724.3K50k shares$14.49--
ARS Pharmaceuticals, Inc.SPRY$8.2M767.6k sharesGrant / ExerciseJan 2, 2025$8.2M767.6k shares$10.71--
ARS Pharmaceuticals, Inc.SPRY$2.8M261.9k sharesGrant / ExerciseJan 2, 2025$2.8M261.9k shares$10.71--
ARS Pharmaceuticals, Inc.SPRY$15M1.3M sharesSellDec 17, 2024$583.6K50k shares$11.67--
ARS Pharmaceuticals, Inc.SPRY$13M1.1M sharesSellDec 17, 2024$583.5K50k shares$11.67--
ARS Pharmaceuticals, Inc.SPRY$16M1.2M sharesSellDec 10, 2024$658.3K50k shares$13.17--
ARS Pharmaceuticals, Inc.SPRY$15M1.1M sharesSellDec 10, 2024$658.2K50k shares$13.16--
ARS Pharmaceuticals, Inc.SPRY$2.8M338.1k sharesGrant / ExerciseDec 6, 2024$100.0K11.9k shares$8.42--
ARS Pharmaceuticals, Inc.SPRY$30k20.7k sharesGrant / ExerciseDec 6, 2024$19.9K13.8k shares$1.44--
ARS Pharmaceuticals, Inc.SPRY$19M1.3M sharesSellNov 19, 2024$697.5K50k shares$13.95--
ARS Pharmaceuticals, Inc.SPRY$17M1.2M sharesSellNov 19, 2024$697.5K50k shares$13.95--
ARS Pharmaceuticals, Inc.SPRY$21M1.3M sharesSellNov 12, 2024$756.3K45.1k shares$16.76--
ARS Pharmaceuticals, Inc.SPRY$22M1.3M sharesSellNov 12, 2024$754.9K45k shares$16.76--
ARS Pharmaceuticals, Inc.SPRY$23M1.3M sharesSellNov 12, 2024$87.4K5k shares$17.64--
ARS Pharmaceuticals, Inc.SPRY$22M1.2M sharesSellNov 12, 2024$86.0K4.9k shares$17.64--
ARS Pharmaceuticals, Inc.SPRY$19M1.3M sharesSellOct 15, 2024$743.8K50k shares$14.88--
ARS Pharmaceuticals, Inc.SPRY$21M1.4M sharesSellOct 15, 2024$721.7K48.6k shares$14.86--
ARS Pharmaceuticals, Inc.SPRY$21M1.4M sharesSellOct 15, 2024$22.1K1.5k shares$15.25--
ARS Pharmaceuticals, Inc.SPRY$19M1.3M sharesSellOct 8, 2024$691.4K50k shares$13.83--
ARS Pharmaceuticals, Inc.SPRY$19M1.3M sharesSellOct 8, 2024$691.4K50k shares$13.83--
ARS Pharmaceuticals, Inc.SPRY$18M1.4M sharesSellSep 17, 2024$646.7K50k shares$12.93--
ARS Pharmaceuticals, Inc.SPRY$19M1.4M sharesSellSep 17, 2024$646.5K50k shares$12.93--
ARS Pharmaceuticals, Inc.SPRY$17M1.4M sharesSellSep 10, 2024$574.9K50k shares$11.50--
ARS Pharmaceuticals, Inc.SPRY$16M1.4M sharesSellSep 10, 2024$574.9K50k shares$11.50--
ARS Pharmaceuticals, Inc.SPRY$22M1.5M sharesSellAug 20, 2024$534.5K36.2k shares$14.76--
ARS Pharmaceuticals, Inc.SPRY$22M1.5M sharesSellAug 20, 2024$530.4K35.9k shares$14.76--
ARS Pharmaceuticals, Inc.SPRY$23M1.5M sharesSellAug 20, 2024$183.5K11.8k shares$15.61--
ARS Pharmaceuticals, Inc.SPRY$23M1.5M sharesSellAug 20, 2024$180.0K11.5k shares$15.62--
ARS Pharmaceuticals, Inc.SPRY$24M1.5M sharesSellAug 20, 2024$37.4K2.3k shares$16.26--
ARS Pharmaceuticals, Inc.SPRY$24M1.5M sharesSellAug 20, 2024$36.7K2.3k shares$16.25--
ARS Pharmaceuticals, Inc.SPRY$18M1.4M sharesSellAug 13, 2024$451.9K35.4k shares$12.76--
ARS Pharmaceuticals, Inc.SPRY$20M1.5M sharesSellAug 13, 2024$451.4K35.4k shares$12.77--
ARS Pharmaceuticals, Inc.SPRY$19M1.6M sharesSellAug 13, 2024$172.3K14.6k shares$11.77--
ARS Pharmaceuticals, Inc.SPRY$17M1.5M sharesSellAug 13, 2024$171.9K14.6k shares$11.78--
ARS Pharmaceuticals, Inc.SPRY$18M1.6M sharesSellJul 16, 2024$570.2K50k shares$11.40--
ARS Pharmaceuticals, Inc.SPRY$18M1.5M sharesSellJul 16, 2024$570.1K50k shares$11.40--
ARS Pharmaceuticals, Inc.SPRY$14M1.5M sharesSellJul 9, 2024$480.9K50k shares$9.62--
ARS Pharmaceuticals, Inc.SPRY$16M1.6M sharesSellJul 9, 2024$480.8K50k shares$9.62--
ARS Pharmaceuticals, Inc.SPRY$16M1.7M sharesSellJun 12, 2024$439.2K48k shares$9.14--
ARS Pharmaceuticals, Inc.SPRY$14M1.5M sharesSellJun 12, 2024$437.5K47.8k shares$9.15--
ARS Pharmaceuticals, Inc.SPRY$14M1.6M sharesSellJun 11, 2024$19.5K2.2k shares$9.00--
ARS Pharmaceuticals, Inc.SPRY$16M1.7M sharesSellJun 11, 2024$17.8K2k shares$9.00--